Bayer Aktiengesellschaft - Depositary Receipt (BAYRY) Price Target Increased by 13.56% to 10.61

Bayer Aktiengesellschaft (OTCPK:BAYRY) has received an updated average one-year price target of $10.61 per share, marking a 13.56% increase from the prior estimate and representing a 45.29% upside from its latest closing price. While the number of institutional owners decreased by 7.41%, total institutional shares held in BAYRY rose 8.51% to 24,021K, and the average portfolio weight dedicated to the stock by these funds increased by 21.00%, signaling growing conviction among institutional investors despite fewer participants.

Analysis

The average one-year price target for Bayer Aktiengesellschaft (OTCPK:BAYRY) has been significantly revised upwards to $10.61 per share, marking a 13.56% increase from the prior estimate of $9.34. This new target implies a substantial 45.29% upside from the latest reported closing price of $7.30, reflecting a strong bullish outlook from analysts.

Despite a 7.41% decrease in the number of institutional owners over the last quarter, total institutional shares held in BAYRY increased by 8.51% to 24,021K. Concurrently, the average portfolio weight dedicated to BAYRY by these funds rose by 21.00% to 0.71%, indicating a concentrated bullish stance among the remaining institutional investors.

Specific institutional actions reinforce this trend, with Eagle Capital Select Equity ETF increasing its holdings by 12.41% and Kahn Brothers Group by 2.31%, both significantly raising their portfolio allocation to BAYRY. While TSW Large Cap Value Fund Advisor Shares reduced its position by 36.05%, the overall institutional flow points to strong net accumulation and increased conviction in the stock.

Key Decisions for Investors

• Investors should consider the substantial 45.29% implied upside to the revised average price target of $10.61 for BAYRY, suggesting significant potential appreciation.
• The observed net institutional accumulation and increased average portfolio weighting, despite fewer reporting funds, signal growing conviction among sophisticated investors.
• Monitor for continued institutional buying trends and company-specific catalysts that could further validate this bullish sentiment and drive price performance.